Status:
RECRUITING
Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma
Lead Sponsor:
Hospital Universitari de Bellvitge
Conditions:
Asthma
Telemedicine
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Introduction: Asthma is one of the most common chronic respiratory diseases worldwide. Despite the extensive knowledge of the condition and available therapeutic options, severe asthmatic patients hav...
Detailed Description
Design: A 52-week randomized clinical trial will be conducted, using a single-blind approach, in patients with asthma. There will be two study arms: the control cohort will receive standard care, whil...
Eligibility Criteria
Inclusion
- Age ≥18 years with a diagnosis of asthma based on GEMA 5.2 2022.
- Patients seen in the pulmonology service of the center.
- Patients who have not previously received asthma education.
- Capable of giving signed informed consent.
Exclusion
- Patient who does not have a mobile device with Android or IOS system.
- Lack of minimum technological knowledge for the use of the application (ESTOI).
- People who are participating or have participated in a clinical trial in the last 6 months.
- Patients diagnosed with other respiratory diseases except for obstructive sleep apnea (OSA), Asthma-COPD overlap syndrome (ACOS).
- Patients with palliative or severe chronic illnesses that limit their life expectancy.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT06116292
Start Date
January 1 2024
End Date
December 31 2026
Last Update
October 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bellvitge University Hospital
Barcelona, Barcelona, Spain, 08907